JUPW Stock Price, Jupiter Wellness, Inc. Quote, Chart

JUPW Stock Price

View Fullscreen

JUPW RSI Chart

JUPW Valuation

Market Cap

64.6M

Price/Earnings (Trailing)

-2.19

Price/Sales (Trailing)

318.89

Price/Free Cashflow

-4.11

JUPW Price/Sales (Trailing)

JUPW Profitability

Operating Margin

-1443.34%

Return on Equity

-528.67%

Return on Assets

-319.59%

Free Cashflow Yield

-24.31%

JUPW Fundamentals

JUPW Revenue

Revenue (TTM)

202.7K

Rev. Growth (Yr)

-84.78%

Rev. Growth (Qtr)

-81.08%

JUPW Earnings

Earnings (TTM)

-29.4M

Earnings Growth (Yr)

-1.1K%

Earnings Growth (Qtr)

-176.11%

Breaking Down JUPW Revenue

Last 7 days

6.8%

Last 30 days

86.9%

Last 90 days

366.6%

Trailing 12 Months

60.9%

How does JUPW drawdown profile look like?

JUPW Financial Health

Current Ratio

1.28

Debt/Equity

0.19

Debt/Cashflow

-14.62

JUPW Investor Care

Shares Dilution (1Y)

62.40%

Diluted EPS (TTM)

-0.79

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	141.1K	161.6K	182.2K	202.7K
2022	167.5K	151.9K	136.3K	120.6K
2021	845.0K	624.4K	403.8K	183.1K
2020	0	0	0	1.1M
2019	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Jupiter Wellness, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Aug 31, 2023	gulyas john	bought	-	-	1,666,670	-
Aug 07, 2023	gulyas john	bought	-	-	18,500	-
Oct 25, 2022	fani skender	bought	172,962	0.9	192,180	-
Oct 25, 2022	fani skender	bought	57,654	0.9	64,060	-
Oct 24, 2022	fani skender	bought	83.6482	0.8282	101	-
Oct 20, 2022	fani skender	bought	47,422	0.8199	57,839	-
Jul 26, 2022	john brian	back to issuer	-	-	-18,832	ceo
Jul 26, 2022	john brian	back to issuer	-	-	-56,496	ceo
Jul 26, 2022	wilson glynn	back to issuer	-	-	-42,372	cso, chairman
Jul 26, 2022	miller richard a	back to issuer	-	-	-9,416	cco

Which funds bought or sold JUPW recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	COMERICA BANK	unchanged	-	-1,120	2,390	-%
May 16, 2024	JANE STREET GROUP, LLC	reduced	-57.72	-134,594	54,413	-%
May 16, 2024	Clear Point Advisors Inc.	unchanged	-	-44.00	96.00	-%
May 15, 2024	Royal Bank of Canada	sold off	-100	-6,000	-	-%
May 15, 2024	PRELUDE CAPITAL MANAGEMENT, LLC	sold off	-100	-35,100	-	-%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	sold off	-100	-113,443	-	-%
May 15, 2024	Mariner, LLC	new	-	31,070	31,070	-%
May 15, 2024	Tower Research Capital LLC (TRC)	reduced	-35.95	-3,182	2,462	-%
May 15, 2024	Cubist Systematic Strategies, LLC	sold off	-100	-92,376	-	-%
May 15, 2024	Engineers Gate Manager LP	sold off	-100	-149,670	-	-%

Are Funds Buying or Selling JUPW?

Are funds buying JUPW calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own JUPW

No. of Funds

Unveiling Jupiter Wellness, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 17, 2024	core 4 capital corp.	6.8%	3,494,657	SC 13G
Oct 17, 2023	greentree financial group, inc	9.9%	3,721,876	SC 13G/A
May 13, 2022	greentree financial group, inc	9.9%	2,193,496	SC 13G

Recent SEC filings of Jupiter Wellness, Inc.

View All Filings

Date Filed	Form Type	Document
May 15, 2024	10-Q	Quarterly Report
May 15, 2024	8-K	Current Report
May 14, 2024	8-K	Current Report
May 13, 2024	8-K	Current Report
May 06, 2024	144	Notice of Insider Sale Intent
May 06, 2024	8-K	Current Report
May 03, 2024	8-K	Current Report
May 01, 2024	3	Insider Trading
Apr 26, 2024	8-K	Current Report
Apr 22, 2024	8-K	Current Report

Jupiter Wellness, Inc. News

Latest updates

Jupiter Wellness, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3
Revenue	-81.1%	171	902	1,634	2,365	1,122	1,748	2,374	3,001	722	705	688	595	454	312	178	458	118	61.00	5.00
Cost Of Revenue	304.9%	2,383	-1,163	46.00	1,862	875	-1,308	74.00	2,495	604	-920	686	414	23.00	191	97.00	237	100	-	3.00
Gross Profit	-428.9%	-2,212	-418	-34.56	504	247	-537	11.00	505	117	-228	2.00	181	25.00	121	82.00	221	18.00	-	2.00
Operating Expenses	148.6%	12,957	5,212	4,091	1,999	1,497	7,880	1,977	1,398	2,979	16,611	3,609	3,839	2,888	-	-	-	-	-	-
S&GA Expenses	-100.0%	-	5,212	4,091	1,999	1,497	6,430	1,977	1,398	1,979	6,311	3,609	3,839	2,888	3,825	650	618	482	-	129
Interest Expenses	-	-	-	-	-	-	-	-	-	-	41.00	1,199	494	1.00	31.00	40.00	36.00	846*	-	66*
Net Income	-176.1%	-15,674	-5,676	-7,738	-359	-1,308	-8,530	-2,332	-1,440	-2,919	-16,944	-4,808	-4,151	-2,195	-4,766	-607	-433	-481	-	-127
Net Income Margin	-95.2%	-145.31*	-74.42*	-98.46*	-77.52*	-96.44*	-126.20*	-173.48*	-171.93*	-172.07*	-153.43*	-39.43*	-18.77*	-9.47*	-5.90*	-	-	-	-	-
Free Cashflow	-7.3%	-6,387	-5,952	-2,720	-682	-1,495	-1,398	-1,338	-1,008	-2,717	-1,502	-1,812	-	-	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet																(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2019Q4
Assets	-27.5%	9,215	12,709	11,331	11,080	10,907	8,691	12,086	14,386	13,295	18,867	31,449	6,325	5,082	6,526	1,766	746
Current Assets	-43.5%	4,344	7,691	8,166	9,170	9,005	6,751	8,401	10,648	10,809	16,280	28,412	4,802	3,589	4,959	535	746
Cash Equivalents	-100.0%	-	3,833	4,388	2,773	3,737	1,478	3,565	5,001	6,146	11,225	26,853	3,941	3,008	4,262	131	531
Inventory	-49.3%	404	796	94.00	328	266	151	397	388	473	249	637	255	249	226	294	135
Net PPE	-9.4%	26.00	28.00	31.00	149	83.00	52.00	87.00	72.00	63.00	102	107	-	33.00	36.00	38.00	-
Goodwill	-	-	-	-	942	942	942	942	942	942	942	942	942	942	942	309	-
Liabilities	-6.4%	3,644	3,892	4,622	5,411	5,099	5,025	3,529	3,689	1,641	2,265	1,822	2,608	651	2,132	2,557	367
Current Liabilities	-5.3%	3,397	3,587	4,263	4,997	4,637	4,506	2,964	3,068	1,020	1,569	1,102	2,608	651	2,126	2,527	336
Long Term Debt	0%	1,070	1,070	-	-	-	477	477	285	285	285	228	328	336	1,075	445	325
LT Debt, Current	4.6%	1,570	1,500	2,000	2,000	2,000	2,000	1,892	1,397	-	-	-	2,005	-	525	-	-
Shareholder's Equity	-36.8%	5,571	8,817	6,709	5,669	5,808	3,666	8,557	10,697	11,654	16,602	29,627	3,717	4,431	4,394	-	379
Retained Earnings	-23.9%	-81,355	-65,680	-60,003	-52,265	-51,905	-50,597	-42,067	-39,735	-38,294	-35,374	-18,429	-13,621	-9,470	-7,274	-2,507	-985
Additional Paid-In Capital	17.3%	86,459	73,727	65,950	57,430	57,210	53,764	50,426	50,322	51,775	51,668	47,805	16,998	13,554	11,657	1,265	1,033
Shares Outstanding	7.9%	49,220	45,634	37,209	32,434	31,837	22,339	22,192	26,908	27,632	24,046	16,903	13,456	13,341	12,727	-	-
Float	-	-	-	-	23,240	-	-	-	12,153	-	-	-	30,417	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3
Cashflow From Operations	-7.3%	-6,387	-5,952	-2,665	-627	-1,469	-1,418	-1,319	-996	-2,712	-1,506	-1,780	-1,982	-1,254	-1,417	-465	-391	-457	-	-
Share Based Compensation	-	663	-	-	220	-	2,844	296	-	105	3,849	1,875	1,990	1,673	2,247	103	-	47.00	-	-
Cashflow From Investing	147.8%	809	-1,692	1,913	-524	-26.08	-	-194	-1,312	-961	-14,114	-475	-	-	43.00	-	-245	-44.00	-	-
Cashflow From Financing	-43.1%	3,792	6,670	2,640	188	3,302	42.00	-175	1,164	-1,934	71.00	25,168	-	-	5,505	295	580	330	-	-
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

JUPW Income Statement

2024-03-31

Condensed Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Sales	$ 170,732	$ 34,788
Cost of Sales	2,383,285	23,965
Gross profit	(2,212,553)	10,823
Operating expense
General and administrative expenses	12,956,552	1,244,953
Total operating expenses	12,956,552	1,244,953
Other income / (expense)
Interest income	4,032	369
Interest expense	(61,831)	(58,552)
Gain on sale of marketable securities	151,388
Unrecognized loss on equity investment	(599,155)
Other income / (expense)		(99)
Total other income (expense)	(505,566)	(58,282)
Loss from operations	(15,674,671)	(1,292,412)
Loss from discontinued operations		(15,762)
Net loss	$ (15,674,671)	$ (1,308,174)
Net (loss) per share:
Basic	$ (0.33)	$ (0.05)
Weighted average number of shares
Basic	47,435,503	25,551,752

JUPW Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Assets
Cash	$ 2,046,355	$ 3,833,349
Marketable Securities	242,613	842,976
Inventory	403,763	795,824
Account receivable	5,153	5,585
Prepaid expenses and deposits	1,590,181	1,469,733
Other current assets	56,364	86,174
Total current assets	4,344,429	7,690,824
Right of use assets	435,623	479,027
Intangible assets, net of amortization	4,409,207	4,511,057
Fixed assets, net of depreciation	25,621	28,272
Total assets	9,214,880	12,709,180
Liabilities and Shareholders’ Equity
Accounts Payable	1,053,812	1,493,809
Convertible notes	1,569,669	1,500,000
Current portion of lease liability	226,030	214,752
Accrued interest	233,561	269,152
Accrued liabilities	264,564	60,450
Covid - 19 SBA Loan	49,289	48,974
Total current Liabilities	3,396,925	3,587,137
Long-term portion lease liability	247,441	304,907
Total liabilities	3,644,366	3,892,044
Preferred stock, $0.001 par value, 100,000 shares authorized of which none are issued and outstanding
Common stock, $.001 par value, 100,000,000 shares authorized, of which 49,220,273 and 45,634,154 shares issued and outstanding as of March 31, 2024 and December 31, 2023	49,220	45,634
Additional paid-in capital	86,458,794	73,726,987
Common stock payable	417,886	725,230
Accumulated deficits	(81,355,386)	(65,680,715)
Total Shareholders’ Equity	5,570,514	8,817,136
Total Liabilities and Shareholders’ Equity	9,214,880	12,709,180
Affiliated Entity [Member]
Assets
Investment in SRM Entertainment, Inc.		$ 657,183

About Jupiter Wellness, Inc.

Jupiter Wellness, Inc., a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.

CEO	Mr. Brian Scott John
WEBSITE	jupiterwellness.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	10

Jupiter Wellness, Inc. Frequently Asked Questions

What is the ticker symbol for Jupiter Wellness, Inc.? What does JUPW stand for in stocks?

JUPW is the stock ticker symbol of Jupiter Wellness, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Jupiter Wellness, Inc. (JUPW)?

As of Tue Apr 30 2024, market cap of Jupiter Wellness, Inc. is 64.63 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of JUPW stock?

You can check JUPW's fair value in chart for subscribers.

What is the fair value of JUPW stock?

You can check JUPW's fair value in chart for subscribers. The fair value of Jupiter Wellness, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Jupiter Wellness, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for JUPW so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Jupiter Wellness, Inc. a good stock to buy?

The fair value guage provides a quick view whether JUPW is over valued or under valued. Whether Jupiter Wellness, Inc. is cheap or expensive depends on the assumptions which impact Jupiter Wellness, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for JUPW.

What is Jupiter Wellness, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 30 2024, JUPW's PE ratio (Price to Earnings) is -2.19 and Price to Sales (PS) ratio is 318.89. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. JUPW PE ratio will change depending on the future growth rate expectations of investors.